Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Barber

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 2018
Data Generated by Quantitative Liquid Chromatography-Mass Spectrometry Proteomics Are Only the Start and Not the Endpoint: Optimization of Quantitative Concatemer-Based Measurement of Hepatic Uridine-5'-Diphosphate-Glucuronosyltransferase Enzymes with Reference to Catalytic ActivityBrahim Achour, Alyssa Dantonio, Mark Niosi, et al.
Molecular Omics|November 17, 2023
Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liverAreti-Maria Vasilogianni, Sarah Alrubia, Eman El-Khateeb, et al.
Pharmacology & Therapeutics|August 4, 2019
Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: Applications in translational pharmacology and recommendations for best practiceEman El-Khateeb, Areti-Maria Vasilogianni, Sarah Alrubia, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 4, 2017
Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes: Comparison of Two Proteomic Methods and Correlation with Catalytic ActivityBrahim Achour, Alyssa Dantonio, Mark Niosi, et al.
Clinical Pharmacology and Therapeutics|November 3, 2020
Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and TransportersBrahim Achour, Zubida M Al-Majdoub, Agnieszka Grybos-Gajniak, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 22, 2020
Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small IntestineNarciso Couto, Zubida M Al-Majdoub, Stephanie Gibson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2020
Label-Free Quantitative Proteomics and Substrate-Based Mass Spectrometry Imaging of Xenobiotic Metabolizing Enzymes in Ex Vivo Human Skin and a Human Living Skin Equivalent ModelNarciso Couto, Jillian R A Newton, Cristina Russo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 21, 2024
Absolute Membrane Protein Abundance of P-gp, BCRP and MRPs in Term Human Placenta Tissue and Commonly Used Cell Systems: Application in PBPK Modeling of Placental Drug DispositionZubida M Al-Majdoub, Jolien J M Freriksen, Angela Colbers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 30, 2025
Absolute membrane protein abundance of P-glycoprotein, breast cancer resistance protein, and multidrug resistance proteins in term human placenta tissue and commonly used cell systems: Application in physiologically based pharmacokinetic modeling of placental drug dispositionZubida M Al-Majdoub, Jolien J M Freriksen, Angela Colbers, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 10, 2023
Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modellingJill Barber, Zubida M Al-Majdoub, Narciso Couto, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 2018
Data Generated by Quantitative Liquid Chromatography-Mass Spectrometry Proteomics Are Only the Start and Not the Endpoint: Optimization of Quantitative Concatemer-Based Measurement of Hepatic Uridine-5'-Diphosphate-Glucuronosyltransferase Enzymes with Reference to Catalytic ActivityBrahim Achour, Alyssa Dantonio, Mark Niosi, et al.
Molecular Omics|November 17, 2023
Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liverAreti-Maria Vasilogianni, Sarah Alrubia, Eman El-Khateeb, et al.
Pharmacology & Therapeutics|August 4, 2019
Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: Applications in translational pharmacology and recommendations for best practiceEman El-Khateeb, Areti-Maria Vasilogianni, Sarah Alrubia, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 4, 2017
Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes: Comparison of Two Proteomic Methods and Correlation with Catalytic ActivityBrahim Achour, Alyssa Dantonio, Mark Niosi, et al.
Clinical Pharmacology and Therapeutics|November 3, 2020
Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and TransportersBrahim Achour, Zubida M Al-Majdoub, Agnieszka Grybos-Gajniak, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 22, 2020
Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small IntestineNarciso Couto, Zubida M Al-Majdoub, Stephanie Gibson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2020
Label-Free Quantitative Proteomics and Substrate-Based Mass Spectrometry Imaging of Xenobiotic Metabolizing Enzymes in Ex Vivo Human Skin and a Human Living Skin Equivalent ModelNarciso Couto, Jillian R A Newton, Cristina Russo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 21, 2024
Absolute Membrane Protein Abundance of P-gp, BCRP and MRPs in Term Human Placenta Tissue and Commonly Used Cell Systems: Application in PBPK Modeling of Placental Drug DispositionZubida M Al-Majdoub, Jolien J M Freriksen, Angela Colbers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 30, 2025
Absolute membrane protein abundance of P-glycoprotein, breast cancer resistance protein, and multidrug resistance proteins in term human placenta tissue and commonly used cell systems: Application in physiologically based pharmacokinetic modeling of placental drug dispositionZubida M Al-Majdoub, Jolien J M Freriksen, Angela Colbers, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 10, 2023
Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modellingJill Barber, Zubida M Al-Majdoub, Narciso Couto, et al.
Pageof 8